{"id":"https://openalex.org/W2321490321","doi":"https://doi.org/10.1358/dof.2014.039.05.2167003","title":"Reducing attrition through early assessment of drug safety: Highlights from the Society of Medicines Research Symposium, held on March 13th, 2014 - National Heart & Lung Institute, Kensington, London, U.K.","display_name":"Reducing attrition through early assessment of drug safety: Highlights from the Society of Medicines Research Symposium, held on March 13th, 2014 - National Heart & Lung Institute, Kensington, London, U.K.","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2321490321","doi":"https://doi.org/10.1358/dof.2014.039.05.2167003","mag":"2321490321"},"language":"en","primary_location":{"id":"doi:10.1358/dof.2014.039.05.2167003","doi":"https://doi.org/10.1358/dof.2014.039.05.2167003","is_oa":false,"landing_page_url":"https://doi.org/10.1358/dof.2014.039.05.2167003","pdf_url":null,"source":{"id":"https://openalex.org/S154339661","display_name":"Drugs of the Future","issn_l":"0377-8282","issn":["0377-8282","2013-0368"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313017","host_organization_name":"Thomson Reuters","host_organization_lineage":["https://openalex.org/P4310313017"],"host_organization_lineage_names":["Thomson Reuters"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs of the Future","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000558940","display_name":"Wendy K. ALDERTON","orcid":"https://orcid.org/0000-0003-0258-0451","observed_orcids":["https://orcid.org/0000-0003-0258-0451"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. Alderton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J. Holder","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Holder","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028049853","display_name":"Richard B. Lock","orcid":"https://orcid.org/0000-0002-3436-9071","observed_orcids":["https://orcid.org/0000-0002-3436-9071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Lock","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5021153088","display_name":"David C. Pryde","orcid":"https://orcid.org/0000-0002-5767-030X","observed_orcids":["https://orcid.org/0000-0002-5767-030X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Pryde","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2535,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.58008491,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"39","issue":"5","first_page":"0373","last_page":"0373"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.42719998955726624,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.42719998955726624,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.19979999959468842,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.054499998688697815,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-attrition","display_name":"drug attrition","score":0.8479999899864197},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6620000004768372},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.6349999904632568},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5070000290870667}],"concepts":[{"id":"https://openalex.org/C2780553607","wikidata":"https://www.wikidata.org/wiki/Q684868","display_name":"Attrition","level":2,"score":0.7827669382095337},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6094081401824951},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41691744327545166},{"id":"https://openalex.org/C74909509","wikidata":"https://www.wikidata.org/wiki/Q10387","display_name":"Gerontology","level":1,"score":0.3510909676551819},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.31866610050201416},{"id":"https://openalex.org/C199343813","wikidata":"https://www.wikidata.org/wiki/Q12128","display_name":"Dentistry","level":1,"score":0.05306363105773926}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1358/dof.2014.039.05.2167003","doi":"https://doi.org/10.1358/dof.2014.039.05.2167003","is_oa":false,"landing_page_url":"https://doi.org/10.1358/dof.2014.039.05.2167003","pdf_url":null,"source":{"id":"https://openalex.org/S154339661","display_name":"Drugs of the Future","issn_l":"0377-8282","issn":["0377-8282","2013-0368"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313017","host_organization_name":"Thomson Reuters","host_organization_lineage":["https://openalex.org/P4310313017"],"host_organization_lineage_names":["Thomson Reuters"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs of the Future","raw_type":"journal-article"},{"id":"doi:10.1358/dof.2014.39.5.2167003","doi":"https://doi.org/10.1358/dof.2014.39.5.2167003","is_oa":false,"landing_page_url":"https://doi.org/10.1358/dof.2014.39.5.2167003","pdf_url":null,"source":{"id":"https://openalex.org/S154339661","display_name":"Drugs of the Future","issn_l":"0377-8282","issn":["0377-8282","2013-0368"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313017","host_organization_name":"Thomson Reuters","host_organization_lineage":["https://openalex.org/P4310313017"],"host_organization_lineage_names":["Thomson Reuters"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs of the Future","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2182806978","https://openalex.org/W1977212874","https://openalex.org/W2330992869","https://openalex.org/W4362688053","https://openalex.org/W608292465","https://openalex.org/W2103363311","https://openalex.org/W2600723666","https://openalex.org/W1982585920","https://openalex.org/W2042033751","https://openalex.org/W103689249"],"abstract_inverted_index":null,"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}